Cell & Gene Meeting on the Med

Vivet Therapeutics is heading to Rome for the 2024 Cell & Gene Meeting on the Med from 9 – 11 April. Come and listen to our CEO, @Jean-Philippe Combal on 9 April at 10am CEST, where he will deliver a presentation on hashtag#Vivet‘s diversified pipeline of hashtag#rAAV based hashtag#genetherapies for rare inherited liver metabolic disorders […]

J.P.Morgan 2024 – Annual Healthcare Conference in San Francisco

Jean-Philippe Combal – CEO and Gloria Gonzalez – CSO, are going to San Francisco for #JPM24! Let’s make the most of this opportunity. Please send a message if you would like to schedule a meetup: info@vivet-therapeutics.com. #Wilsonsdisease #genetherapy #innovation #letsconnect

AASLD – The Liver Meeting  in Boston

Vivet Therapeutics is pleased to join AASLD – The Liver Meeting  in Boston, MA this year. Meet with Vivet Therapeutics for an update on the GATEWAY gene therapy clinical trial for Wilson disease – booth B908

ESGCT’s 30th Annual Congress in Brussels

Excited to kick off ESGCT’s 30th Annual Congress in Brussels today! Join Vivet’s New Programs and Innovation Lead @Nicholas Weber, Ph.D. as he presents on the topic “Gene Therapy for Metabolic Diseases” on 25 October at 2:30 pm.

Wilson Disease Association’s Annual Conference

Vivet Therapeutics is delighted to sponsor and present at @Wilson Disease Association’s Annual Conference for patients and caregivers. Be sure to tune in to the presentation of CMO Bernard Benichou, MD, Ph.D, and Patient Advocate Lori McKenna Gorski!